Effects of Omacor and Aspirin on Platelet Function
Status:
Completed
Trial end date:
2007-08-01
Target enrollment:
Participant gender:
Summary
Omacor (now Lovaza) is a pharmaceutical omega-3 fatty acid product. Omega-3 fatty acids can
affect blood clotting by altering the function of the blood platelets. Aspirin can do the
same. The purpose of this study is to determine the individual and combined effects of these
two agents on platelet function using a whole blood method.